ECTRIMS, Barcelona 2025
Report by Graham Walker, October 20th. Note from MSNZ: In September 2025 MSNZ Co-Vice President and person with MS Graham Walker and his wife Julie, travelled to Barcelona to attend the 41st European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS). As an active advocate with a strong interest in science, research and […]
Ocrevus Subcutaneous: Valuing the benefits to people living with MS, whānau caregivers, and the health system
Multiple Sclerosis New Zealand (MSNZ) welcomes this timely and evidence-based report from NZIER, commissioned by Roche Products NZ. Representing 18 member organisations and over 5,000 New Zealanders living with MS, along with their whānau, carers and supporters, MSNZ has long advocated for equitable access to life-changing treatments. Over the past decade, therapies like ocrelizumab have […]
Media Release: The Economic Burden Report
Information Release: 8th June 2022 NZIER report: Earlier intervention of Multiple Sclerosis will benefit people with MS and the New Zealand economy A recently released report by the New Zealand Institute of Economic Research (NZIER), commissioned by the Multiple Sclerosis Society of New Zealand (MSNZ) shows that earlier intervention of Multiple Sclerosis (MS) will not […]